Navigation Links
MiMedx Announces Record First Quarter 2013 Results
Date:5/1/2013

;MIMEDX GROUP, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)Three Months Ended March 31,20132012Revenues:Net sales$

11,556,493$

3,705,808Cost of sales1,905,020958,855Gross margin9,651,4732,746,953Operating expenses:Research and development expenses1,246,757407,072Selling, general and administrative expenses8,369,0102,637,269Amortization of intangible assets262,596333,977Operating income (loss) (226,890)(631,365)Other income (expense), netAmortization of debt discount(1,328,439)(310,477)Interest expense, net(14,804)(151,810)Income (loss) before income tax provision(1,570,133)(1,093,652)Income tax provision(50,275)-Net Income (loss)

$

(1,620,408)$

(1,093,652)Net income (loss) per common share - basic and diluted

$

(0.02)$

(0.01)Weighted average shares outstanding - basic and diluted93,128,46674,872,122 

MIMEDX GROUP, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETSASSETSMarch 31,December 31,20132012(unaudited)Current assets:Cash and cash equivalents

$

5,725,107

$

6,754,485Accounts receivable, net9,821,5037,653,561Inventory, net3,956,3393,022,784Prepaid expenses and other current assets1,186,417657,961Total current assets20,689,36618,088,791Property and equipment, net of accumulated depreciation of $2,378,590 and $2,279,840, respectively1,153,6671,071,625Goodwill4,040,4434,040,443Intangible assets, net of accumulated amortization of $5,111,352 and $4,848,756, respectively11,649,15311,911,749Deposits and other long term assets319,54570,000Total assets

$

37,852,174

$

35,182,608LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$

1,056,707

$

1,251,684Accrued compensation3,518,7692,753,237Accrued expenses1,227,485990,697Other current liabilities167,60075,154Total current liabilities5,970,5615,070,772Earn-out liabili
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
2. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
3. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
4. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
5. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
6. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
7. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
8. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
9. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
10. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
11. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Dallas, Texas (PRWEB) September 23, 2014 ... report on the Global and China Isopropanol (IPA) ... the industry, including definitions, applications and industry chain ... analysis are provided with a focus on history, ... A comparison between the international and Chinese situation ...
(Date:9/23/2014)...   GenoSpace , a precision medicine software company ... enable the broad use of genomic data in research ... awarded Phase I of a Fast Track Small Business ... Health (NIH) to enable enhanced data access and cohort ... During the past decade, the ...
(Date:9/23/2014)... Texas Fertility Center (TFC) announces the opening of ... Central Texas footprint that includes Round Rock, Central Austin, ... the region’s most established practice will provide full service ... Kyle and San Marcos communities. , “We want ... individuals and couples living in and around South Austin,” ...
(Date:9/23/2014)... Dr. Williams says, “Find The Black ... offers a three phase process that can lead to ... that would go far beyond anything previously imagined. First ... of healthcare.” , “Every effort to improve the quality ... discernable progress throughout that system because all of the ...
Breaking Biology Technology:(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 2Opening Doors to a Family: Texas Fertility Center Announces Newest Fertility Clinic in South Austin 3Dr. Ira Williams Offers the Healthcare Solution Necessary for Patient Safety Improvement 2
... N.J., May 9 Barr Pharmaceuticals,Inc. (NYSE: ... Laboratories,Inc., has received final approval from the U.S. ... Drug Application (ANDA) to,manufacture and market a generic ... contraceptive product manufactured and marketed,by Bayer Schering Pharma, ...
... May 9 Genaera,Corporation (Nasdaq: GENR ) today announced ... net loss for the quarter ended March 31,2008 was $4.3 ... a net loss of $4.2 million, or $(0.24) per basic ... Genaera,s research and development expenses for the quarter ended March,31, ...
... 9 Schering-Plough,Corporation (NYSE: SGP ) will hold ... Memphis, Tenn. At 8 a.m. (CDT) (9 a.m. EDT) ... be available to all interested,parties via the corporate Web ... Fred Hassan, Chairman and CEO, will report to,shareholders on ...
Cached Biology Technology:Barr Announces Approval of Generic Yasmin(R) 2Barr Announces Approval of Generic Yasmin(R) 3Genaera Corporation Announces First Quarter Financial Results 2Genaera Corporation Announces First Quarter Financial Results 3Genaera Corporation Announces First Quarter Financial Results 4
(Date:9/23/2014)... the effects of temperature on insects to predict how ... a Dartmouth study shows for the first time that ... ultimately limits how fast they grow. , "In other ... overall environmental conditions that shape the growth, survival and ... Lauren Culler , an Arctic postdoctoral researcher at Dartmouth. ...
(Date:9/23/2014)... scientists has identified a gene mutation that causes ... the bone marrow fails to produce normal amounts ... three generations had blood disorders, the researchers discovered ... chromosomal structures with crucial roles in normal cell ... suggest future molecular-based treatments that bypass the gene ...
(Date:9/23/2014)... 23, 2014 Research and Markets  has ... Forecast and Opportunities, 2019" report to their offering. ... for enhancing security and protection in private as well ... The country,s government is focusing on using biometric systems ... other national IDs that are of crucial importance to ...
Breaking Biology News(10 mins):Insects' fear limits boost from climate change, Dartmouth study shows 2Gene mutation discovered in blood disorder 2India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3
... can be swallowed like a pill, injected through a ... to screen for, detect, and potentially treat, cancer and ... size in early development stages. They will also ... researchers at McMaster University will be escalating efforts to ...
... some teenagers taking common anti-depressants may become more aggressive ... the October Behavioral Neuroscience, which is published by the ... of Texas at Austin found that juvenile hamsters given ... the United States as Prozac, became more aggressive on ...
... not be necessary in the event of a large-scale ... a study led by researchers at Fred Hutchinson Cancer ... of Infectious Diseases. , Instead, the current U.S. government ... vaccination of hospital workers and close contacts would be ...
Cached Biology News:Nano-devices hold promise for early-stage cancer detection 2Nano-devices hold promise for early-stage cancer detection 3Adolescent but not adult hamsters are more aggressive on low dose of fluoxetine 2Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 2Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 3Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 4Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack 5
... BR4i refrigerated multifunction centrifuges are equally capable of ... low sound level with a large range of ... rotor exchange system without tools ensures that the ... Instant rotor exchange (5 sec.) ...
... ,Each upright model provides fast pull-down, rapid ... for refrigerated blood. The BBR25 and BBR55 ... complete blood storage monitoring. Models BBR6, BBR11, ... HemaPro 101 alarm/monitor. All of these models ...
Sterile, individually wrapped, 4mm Cuvettes...
... form of Tobacco Etch Virus (TEV) protease ... significantly more stable than native TEV protease, ... recognizes a seven amino acid (Glu-Asn-Leu-Tyr-Phe-Gln-Gly, cleaving ... for removing affinity tags from fusion proteins ...
Biology Products: